The role of therapeutic plasma exchange in pemphigus vulgaris

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue 1, 2011, Pages 82-86

  Sagi, L ^a   Baum, S ^a   Gendelman, V ^b   Trau, H ^a   Barzilai, A ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b MAGEN DAVID ADOM   (Israel)

Author keywords

pemphigus; plasmapheresis; therapeutic plasma exchange

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; IMMUNOGLOBULIN; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIZZINESS; DRUG PULSE THERAPY; FEMALE; HEADACHE; HUMAN; MALE; PEMPHIGUS VULGARIS; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; TREATMENT PLANNING; TREATMENT RESPONSE;

CYCLOPHOSPHAMIDE; DEXAMETHASONE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PEMPHIGUS; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78649984062     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2010.03703.x     Document Type: Article

References (24)

1. Bystryn JC, Steinman NM,. The adjuvant therapy of pemphigus. An update. Arch Dermatol 1996; 132: 203-212.
2. McLeod BC,. Introduction to the third special issue: clinical applications of therapeutic apheresis. J Clin Apher 2000; 15: 1-5.
3. Yeh SW, Sami N, Ahmed RA,. Treatment of pemphigus vulgaris: current and emerging options. Am J Clin Dermatol 2005; 6: 327-342.
4. Tan-Lim R, Bystryn JC,. Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies. J Am Acad Dermatol 1990; 22: 35-40.
5. Murrell DF, Dick S, Ahmed AR, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol 2008; 58: 1043-1046.
6. Cotterill JA, Barker DJ, Millard LG,. Plasma exchange in the treatment of pemphigus vulgaris. Br J Dermatol 1978; 98: 243.
7. Ruocco V, Rossi A, Argenziano G, et al. Pathogenicity of the intercellular antibodies of pemphigus and their periodic removal from the circulation by plasmapheresis. Br J Dermatol 1978; 98: 237-241.
8. Bystryn JC, Graf MW, Uhr JW,. Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med 1970; 132: 1279-1287.
9. Auerbach R, Bystryn JC,. Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris. Arch Dermatol 1979; 115: 728-730.
10. Meurer M, Braun-Falco O,. Plasma exchange in the treatment of pemphigus vulgaris. Br J Dermatol 1979; 100: 231-232.
11. Ruocco V, Astarita C, Pisani M,. Plasmapheresis as an alternative or adjunctive therapy in problem cases of pemphigus. Dermatologica 1984; 168: 219-223.
12. Euler HH, Loffler H, Christophers E,. Synchronization of plasmapheresis and pulse cyclophosphamide therapy in pemphigus vulgaris. Arch Dermatol 1987; 123: 1205-1210.
13. Fine JD, Appell ML, Green LK, et al. Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine. Arch Dermatol 1988; 124: 236-239.
14. Blaszczyk M, Chorzelski TP, Jablonska S, et al. Indications for future studies on the treatment of pemphigus with plasmapheresis. Arch Dermatol 1989; 125: 843-844.
15. Ogata K, Yasuda K, Matsushita M, et al. Successful treatment of adolescent pemphigus vulgaris by immunoadsorption method. J Dermatol 1999; 26: 236-239.
16. Yano C, Ishiji T, Kamide R, et al. A case of pemphigus vulgaris successfully treated with single filtration plasmapheresis: a correlation of clinical disease activity with serum antibody levels. J Dermatol 2000; 27: 380-385.
17. Turner MS, Sutton D, Sauder DN,. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2000; 43: 1058-1064.
18. Sondergaard K, Carstens J, Zachariae H,. The steroid-sparing effect of long-term plasmapheresis in pemphigus: an update. Ther Apher 1997; 1: 155-158.
19. Guillaume JC, Roujeau JC, Morel P, et al. Controlled study of plasma exchange in pemphigus. Arch Dermatol 1988; 124: 1659-1663.
20. Nagasaka T, Fujii Y, Ishida A, et al. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay. Br J Dermatol 2008; 158: 685-690.
21. Bystryn JC,. Plasmapheresis therapy of pemphigus. Arch Dermatol 1988; 124: 1702-1704.
22. Charlton B, Schindhelm K, Smeby LC, et al. Analysis of immunoglobulin G kinetics in the non-steady state. J Lab Clin Med 1985; 105: 312-320.
23. Dau PC,. Immunologic rebound. J Clin Apher 1995; 10: 210-217.
24. Aoyama Y, Nagasawa C, Nagai M, et al. Severe pemphigus vulgaris: successful combination therapy of plasmapheresis followed by intravenous high-dose immunoglobulin to prevent rebound increase in pathogenic IgG. Eur J Dermatol 2008; 18: 557-560.